Adaptive and Acquired Resistance to EGFR Inhibitors Converge on the MAPK Pathway
Adaptive and Acquired Resistance to EGFR Inhibitors Converge on the MAPK Pathway
- Theranostics 2016
- 6:8
--Medical Technology--Medtech
--Medical Technology--Medtech